Immunostaining data for 27 protein markers (Glycodelin and its glyco-modification Glycodelin A, steroid hormone receptors (ERα, ERβ, PRA, PRB, and GPER), gonadotropins-/receptors (hCG, LHCGR, and FSHR), Galectins (Gal-1, Gal-3, Gal-7, Gal-8, and Gal-9), p53, Mucin-1 (as detected by anti-peptide antibodies: VU3C6, VU4H5, HMFG1) and glyco-modifications of Mucin-1 (TA-MUC1 as detected by Gatipotuzumab, TF (CD176)) were available in 32 ovarian cancer cases. This evidence concerns the gene RB1 and ovarian carcinoma.